NO20006382L - Fremgangsmåte for behandling av organofosfatforgiftning - Google Patents

Fremgangsmåte for behandling av organofosfatforgiftning

Info

Publication number
NO20006382L
NO20006382L NO20006382A NO20006382A NO20006382L NO 20006382 L NO20006382 L NO 20006382L NO 20006382 A NO20006382 A NO 20006382A NO 20006382 A NO20006382 A NO 20006382A NO 20006382 L NO20006382 L NO 20006382L
Authority
NO
Norway
Prior art keywords
organophosphate poisoning
treating organophosphate
treating
poisoning
mammal
Prior art date
Application number
NO20006382A
Other languages
English (en)
Other versions
NO20006382D0 (no
Inventor
Herman Hendrik Peter Ma Helden
Nicolaas Henricus Weren Xanten
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Publication of NO20006382D0 publication Critical patent/NO20006382D0/no
Publication of NO20006382L publication Critical patent/NO20006382L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for behandling av organofosfatforgiftning hos et pattedyr, omfattende å administrere en Ai-reseptor-adenosin-agonist.
NO20006382A 1998-06-15 2000-12-14 Fremgangsmåte for behandling av organofosfatforgiftning NO20006382L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/097,505 US20020058669A1 (en) 1998-06-15 1998-06-15 Process for the treatment of organophosphate poisoning
PCT/NL1998/000343 WO1999065501A1 (en) 1998-06-15 1998-06-15 A process for the treatment of organophosphate poisoning

Publications (2)

Publication Number Publication Date
NO20006382D0 NO20006382D0 (no) 2000-12-14
NO20006382L true NO20006382L (no) 2001-01-24

Family

ID=26647321

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006382A NO20006382L (no) 1998-06-15 2000-12-14 Fremgangsmåte for behandling av organofosfatforgiftning

Country Status (5)

Country Link
US (1) US20020058669A1 (no)
EP (1) EP1087776A1 (no)
CN (1) CN1301167A (no)
NO (1) NO20006382L (no)
WO (1) WO1999065501A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247639B2 (en) * 2003-06-06 2007-07-24 Endacea, Inc. A1 adenosine receptor antagonists
JP2011503517A (ja) * 2006-11-13 2011-01-27 アテリス テクノロジーズ，エルエルシー 農薬バイオマーカー
WO2010045615A2 (en) 2008-10-16 2010-04-22 Cenomed Biosciences, Llc Treatment of organophosphate exposure with ocinaplon
CN116509817A (zh) * 2023-04-13 2023-08-01 中国人民解放军军事科学院军事医学研究院 一种腺苷受体伴随开放血脑屏障的纳米药物、其制备方法及对抗神经毒剂中毒的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5356690A (en) * 1976-09-30 1978-05-23 Rikagaku Kenkyusho Purin compund sugar derivatives and their preparation
WO1995002604A1 (en) * 1993-07-13 1995-01-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists

Also Published As

Publication number Publication date
NO20006382D0 (no) 2000-12-14
US20020058669A1 (en) 2002-05-16
EP1087776A1 (en) 2001-04-04
WO1999065501A1 (en) 1999-12-23
CN1301167A (zh) 2001-06-27

Similar Documents

Publication Publication Date Title
US5789416B1 (en) N6 mono heterocyclic substituted adenosine derivatives
DE69700748D1 (de) Egm aufzeichnungssystem für implantierbare medizinische vorrichtung
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
DK0733628T3 (da) 5-substituerede 3-(1,2,3,6-tetrahydropyridin-4-yl)- og 3-(piperidin-4-yl)-1H-indoler: 5HT1F-agonister
DE69637843D1 (de) Verbundfolie-feuchtigkeitssperre für zellentester
NO974290D0 (no) Inhibitorer for rotamase enzym-aktivitet
NO974213L (no) Små-molekylære inhibitorer for rotamase-enzym-aktivitet
WO2001077951A8 (en) System and methods for group retirement plan administration
DE69636998D1 (de) Bidirekektionssperrender akkumulations-grabenleitungs-mosfet
BR9907256A (pt) Inibidores beta-cetoamida de proteassoma 20s
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
NO970519D0 (no) Behandling av type II diabetes mellitus med amylinagonister
NO883505L (no) Fremgangsmaate for analyse av fluidums-innstroemning i oljebroenner.
NO990449D0 (no) FremgangsmÕte for hydrogenbehandling
EP1003494A4 (en) (d) -METHADONE, NON-OPIOID ANALGESIC
NO20006382L (no) Fremgangsmåte for behandling av organofosfatforgiftning
TR199900762T2 (xx) Stresle aktifle�tirilen protein kinazlar�n�n engellenme y�ntemi.
TR199800478T1 (xx) Diarilalkenilamin t�revleri
BR9610075A (pt) Inibidores prolil endopeptidase
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
DE69620944D1 (de) Halbleiter-Prüfmethode
KR960702945A (ko) Amg eprom의 액세스 트랜지스터 영역에서 비트라인-비트라인 누설 전류를 방지하기 위한 방법(a method for preventing bit line-to-bit line leakage in the access transistor region of an amg eprom)
TR199900016T2 (xx) Benzo $g] kuinolin t�revleri.
NO991096L (no) Nye fremgangsmÕter
DE69530517D1 (de) Halbleiteranordnung mit isoliertem gate mit implantaten für verbesserte robustheit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application